AU4400593A - Methods and reagents for the determination of immunosuppressive agents - Google Patents
Methods and reagents for the determination of immunosuppressive agentsInfo
- Publication number
- AU4400593A AU4400593A AU44005/93A AU4400593A AU4400593A AU 4400593 A AU4400593 A AU 4400593A AU 44005/93 A AU44005/93 A AU 44005/93A AU 4400593 A AU4400593 A AU 4400593A AU 4400593 A AU4400593 A AU 4400593A
- Authority
- AU
- Australia
- Prior art keywords
- reagents
- determination
- methods
- immunosuppressive agents
- immunosuppressive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89385892A | 1992-06-05 | 1992-06-05 | |
US893858 | 1992-06-05 | ||
PCT/US1993/005197 WO1993025533A1 (en) | 1992-06-05 | 1993-06-01 | Methods and reagents for the determination of immunosuppressive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4400593A true AU4400593A (en) | 1994-01-04 |
Family
ID=25402239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44005/93A Abandoned AU4400593A (en) | 1992-06-05 | 1993-06-01 | Methods and reagents for the determination of immunosuppressive agents |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4400593A (en) |
WO (1) | WO1993025533A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU680946B2 (en) * | 1993-09-08 | 1997-08-14 | Novartis Ag | Assay kit |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830462A (en) * | 1993-02-12 | 1998-11-03 | President & Fellows Of Harvard College | Regulated transcription of targeted genes and other biological events |
US6063625A (en) * | 1993-02-12 | 2000-05-16 | Board Of Trustees Of Leland S, Stanford, Jr. University | Regulated transcription of targeted genes and other biological events |
US5869337A (en) * | 1993-02-12 | 1999-02-09 | President And Fellows Of Harvard College | Regulated transcription of targeted genes and other biological events |
US5834266A (en) * | 1993-02-12 | 1998-11-10 | President & Fellows Of Harvard College | Regulated apoptosis |
US6972193B1 (en) | 1993-02-12 | 2005-12-06 | Board Of Trustees Of Leland Stanford Junior University | Regulated transcription of targeted genes and other biological events |
US6891021B2 (en) | 1993-02-12 | 2005-05-10 | Board Of Trustees Of The Leland Stanford Junior University | Regulated apoptosis |
AU6711994A (en) * | 1993-04-23 | 1994-11-21 | American Home Products Corporation | Rapamycin conjugates and antibodies |
US5504091A (en) * | 1993-04-23 | 1996-04-02 | American Home Products Corporation | Biotin esters of rapamycin |
US7279561B1 (en) | 1993-04-23 | 2007-10-09 | Wyeth | Anti-rapamycin monoclonal antibodies |
ES2295093T3 (en) | 1993-04-23 | 2008-04-16 | Wyeth | CONJUGATES AND RAPAMYCIN ANTIBODIES. |
US5482850A (en) * | 1993-10-29 | 1996-01-09 | New England Biolabs, Inc. | Method for identifying anti-parasitic compounds |
IL112873A (en) | 1994-03-08 | 2005-03-20 | Wyeth Corp | Rapamycin-fkbp12 binding proteins, their isolation and their use |
WO1996012018A2 (en) * | 1994-10-14 | 1996-04-25 | The Salk Institute For Biological Studies | Novel immunophilins and corresponding nucleic acids |
US6187757B1 (en) | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
US5635406A (en) * | 1995-06-07 | 1997-06-03 | Abbott Laboratories | Stabilized standards and calibrators containing rapamycin and tacrolimus bound to anti-rapamycin and anti-tacrolimus antibodies |
US6709873B1 (en) | 1997-04-09 | 2004-03-23 | Isodiagnostika Inc. | Method for production of antibodies to specific sites of rapamycin |
CA2286311A1 (en) * | 1997-04-09 | 1998-10-15 | Isotechnika, Inc. | Method for production of antibodies to specific sites of rapamycin |
DE60010098T2 (en) | 1999-08-24 | 2005-03-31 | Ariad Gene Therapeutics, Inc., Cambridge | 28-EPIRAPALOGE |
US7067526B1 (en) | 1999-08-24 | 2006-06-27 | Ariad Gene Therapeutics, Inc. | 28-epirapalogs |
JP4262594B2 (en) | 2001-06-22 | 2009-05-13 | エフ.ホフマン−ラ ロシュ アーゲー | Soluble complex containing retroviral surface glycoprotein |
US6962982B2 (en) | 2001-06-22 | 2005-11-08 | Roche Diagnostics Corporation | Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
US7094757B2 (en) | 2001-06-22 | 2006-08-22 | Roche Diagnostics Corporation | Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them |
FI116198B (en) | 2001-07-16 | 2005-10-14 | Valtion Teknillinen | A method for immobilizing polypeptides |
ES2326040T3 (en) | 2001-10-19 | 2009-09-29 | Isotechnika Inc. | SYNTHESIS OF CYCLOSPORINE ANALOGS. |
JP2006516548A (en) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | Drug delivery from rapidly gelled polymer compositions |
US7189582B2 (en) * | 2005-04-27 | 2007-03-13 | Dade Behring Inc. | Compositions and methods for detection of sirolimus |
US7642338B2 (en) | 2006-06-20 | 2010-01-05 | Siemens Healthcare Diagnostics Inc. | Tacrolimus standard and methods of using same |
US7883855B2 (en) | 2006-07-21 | 2011-02-08 | Abbott Laboratories | Immunosuppressant drug extraction reagent for immunoassays |
WO2008082979A2 (en) | 2006-12-29 | 2008-07-10 | Abbott Laboratories | Diagnostic test for the detection of a molecule or drug in whole blood |
CA2673296C (en) | 2006-12-29 | 2012-10-16 | Abbott Laboratories | Improved assay for immunosuppressant drugs |
WO2008082984A2 (en) | 2006-12-29 | 2008-07-10 | Abbott Laboratories | Non-denaturing lysis reagent for use with capture-in-solution immunoassay |
US7914999B2 (en) | 2006-12-29 | 2011-03-29 | Abbott Laboratories | Non-denaturing lysis reagent |
EP2245165A4 (en) | 2008-01-11 | 2011-06-01 | Massachusetts Eye & Ear Infirm | Conditional-stop dimerizable caspase transgenic animals |
EP2571487B1 (en) | 2010-05-21 | 2023-01-04 | Siemens Healthcare Diagnostics Inc. | Zwitterionic reagents |
US9593356B2 (en) | 2013-06-11 | 2017-03-14 | Takara Bio Usa, Inc. | Protein enriched microvesicles and methods of making and using the same |
CN104749009B (en) * | 2015-03-30 | 2018-05-04 | 上海云泽生物科技有限公司 | immunosuppressant drug extraction reagent for immunoassay |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
US5047512A (en) * | 1985-05-03 | 1991-09-10 | Handschumacher Robert E | Immobilized cyclophilin and methods of using such |
DE3886265T2 (en) * | 1987-06-05 | 1994-04-28 | Fujisawa Pharmaceutical Co | Anti-FR-900506 substance antibody and highly sensitive enzyme immunoassay method. |
US5124255A (en) * | 1988-03-11 | 1992-06-23 | Abbott Laboratories | CKS method of protein synthesis |
US5196352A (en) * | 1989-01-19 | 1993-03-23 | Merck & Co., Inc. | New FK-506 cytosolic binding protein |
US5109112A (en) * | 1989-01-19 | 1992-04-28 | Merck & Co., Inc. | FK-506 cytosolic binding protein |
EP0482189A1 (en) * | 1990-05-09 | 1992-04-29 | Children's Research Institute | Receptor assay for fk-506 |
-
1993
- 1993-06-01 WO PCT/US1993/005197 patent/WO1993025533A1/en active Application Filing
- 1993-06-01 AU AU44005/93A patent/AU4400593A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU680946B2 (en) * | 1993-09-08 | 1997-08-14 | Novartis Ag | Assay kit |
Also Published As
Publication number | Publication date |
---|---|
WO1993025533A1 (en) | 1993-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4400593A (en) | Methods and reagents for the determination of immunosuppressive agents | |
AU628269B2 (en) | Method and device for the assay of ions | |
AU7098094A (en) | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies | |
AU2597995A (en) | Reagents and methods for the rapid and quantitative assay of pharmacological agents | |
AU3508993A (en) | Analysis of particle characteristics | |
AU2787892A (en) | Highly reactive forms of zinc and reagents thereof | |
AU1322195A (en) | Method of assay | |
AU666605B2 (en) | Reagent for endotoxin assay and method for endotoxin assay using the same | |
AU4535893A (en) | Screening assay for the identification of immunosuppressive drugs | |
AU5734294A (en) | Construction geometry using dof analysis | |
AU4930993A (en) | Coupled replication-translation methods and kits for protein synthesis | |
AU1186695A (en) | Reagents and methods for the detection of methotrexate | |
AU5016793A (en) | Dual functional anti-inflammatory and immunosuppressive agents | |
AU3697393A (en) | Method for the elimination of non-specific reactions in immunoassays | |
AU679274B2 (en) | Reduction of background interferences in the molybdate-dye protein assay | |
AU3385693A (en) | Determination method | |
AU6254694A (en) | Novel macrocomposite bodies and methods for making the same | |
AU6104994A (en) | Apparatus for the quantitative determination of particulate analytes | |
AU7858691A (en) | Plaque-inhibiting protein from bacteroides loeschei and methods for using the same | |
AU4505996A (en) | 7-vinylidene cephalosporins and methods of using the same | |
EP0608117A3 (en) | Antibodies for mevalonic acid and methods for determination of mevalonic acid. | |
AU7677194A (en) | Sulfamethoxazole-specific immunosuppressive agents | |
AU5002196A (en) | Immunosuppressive agents | |
AU7852791A (en) | Assay method for mutagenic agents and kit | |
AU5425194A (en) | Detection of anti-hpa antibodies |